Metabolic bariatric surgery and type 2 diabetes mellitus: An endocrinologist's perspective

Journal of Biomedical Research

Volumn 29, Issue 2, 2015, Pages 105-111

  Ganguly, Sonali ^a   Tan, Hong Chang ^a   Lee, Phong Ching ^a   Tham, Kwang Wei ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Diabetes remission; Metabolic bariatric surgery; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C;

ASIAN; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; ENDOCRINOLOGIST; GASTRIC BANDING; GASTROPLASTY; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RELAPSE; REMISSION; REVIEW; STOMACH BYPASS; WEIGHT REDUCTION;

EID: 84933046522     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.29.20140127     Document Type: Review

References (46)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9131):837-853.
2. ACCORD Study Group, Gerstein HC, Miller ME, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011;364(9):818-828.
3. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013;36(Suppl 1): S11-S66.
4. Dixon JB, Zimmet P, Alberti KG, et al. Bariatric Surgery: An IDF statement for obese Type 2 diabetes. Diabet Med 2011;28(6):628-642.
5. Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care 2008;31(Suppl 2):S290-S296.
6. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222(3):339-350.
7. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes. JAMA 2008;299(3):316-322.
8. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes. N Engl J Med 2012;366(17):1577-85.
9. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes. N Engl J Med 2012;366(17):1567-76.
10. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes-3 Year Outcomes. N Engl J Med 2014;370(21):2002-2013.
11. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric Surgery-A Systemic Review and Analysis. JAMA 2004;292(14):1724-1737.
12. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care 2009;32(11):2133-2135.
13. Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and Hyperlipidemia-The Diabetes Surgery Study Randomized Clinical Trial. JAMA 2013;309(21):2240-2249.
14. Abbatini F, Capoccia D, Casella G, et al. Long-term remission of type 2 diabetes in morbidy obese patients after sleeve gastrectomy. Surg Obes Relat Dis 2013;9(4):498-502.
15. Jimenez A, Casamitjana R, Flores L, et al. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg 2012;256(6):1023-1029.
16. Boza C, Gamboa C, Salinas J, et al. Laparoscopic Rouxen-Y gastric bypass versus laparoscopic sleeve gastrectomy: a case-control study and 3 years of follow-up. Surg Obes Relat Dis 2012;8(3):243-249.
17. Zachariah SK, Chang P, Ooi ASE, et al. Laparascopic Sleeve Gastrectomy for Morbid Obesity: 5 Years Experience from an Asian Center of Excellence. Obes Surg 2013;23(7):939-946.
18. DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid-to long-term follow-up. Surg Obes Relat Dis 2010;6(3):249-253.
19. Brethauer SA, Aminian A, Romero-Talamas H, et al. Can Diabetes Be Surgically Cured? Longterm Metabolic Effects of Bariatric Surgery in Obese Patients with Type 2 Diabetes Mellitus. Ann Surg 2013;258(4):628-636; discussion 636-637.
20. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351(26):2683-2693.
21. Lee WJ, Chong K, Chen JC, et al. Predictors of diabetes remission after bariatric surgery in Asia. Asian J Surg 2012;35(2):67-73.
22. Lee WJ, Hur WY, Lakdawala M, et al. Diabetes surgery score for metabolic surgery. Surg Obes Relat Dis 2013;9(3):379-384.
23. Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes. Diabetes Care 2013;36(8):2175-2182.
24. Dutia R, Brakoniecki K, Bunker P, et al. Limited recovery of b-cell function after gastric bypass despite clinical diabetes remission. Diabetes 2014;63(4):1214-1223.
25. Nannipieri M, Mari A, Anselmino M, et al. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab 2011;96(9):E1372-E1379.
26. Isbell JM, Tamboli RA, Hansen EN, et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 2010;33(7):1438-1442.
27. Lim EL, Hollingsworth KG, Arbisala BS, et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011;54(10):2506-2514.
28. Miras AD, le Roux CW. Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery? Int J Obes (Lond) 2014;38(3):325-333.
29. SalehiM, Prigeon RL, D'Alessio DA. Gastric bypass surgery enhances glucagon-like peptide 1 stimulated postprandial insulin secretion in humans. Diabetes 2011;60(9):2308-2314.
30. Jimenez A, Casamitjana R, Flores L, et al. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects. Ann Surg 2013;257(5):894-899
31. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87(1):4-14.
32. Ramachandran A, Ching RWM, Snehalatha C. Diabetes in Asia. Lancet 2010;375(9712):408-418.
33. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus - present and future perspectives. Nat Rev Endocrinol 2012;8(4):228-236.
34. Nyamdorj R, Pitkäniemi J, Tuomilehto J, et al. Ethnic comparison of the association of undiagnosed diabetes with obesity. Int J Ob 2010;34(2):332-339.
35. Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg 2008;12(5):945-952.
36. Dixon JB, Hur K-Y, Lee W-J, et al. Gastric bypass in type 2 diabetes with BMI <30: weight and weight loss have a major influence on outcomes. Diabet Med 2013;30(4): e127-e134.
37. Malapan K, Goel R, Tai C, et al. Laparoscopic Roux-en-Y gastric bypass for nonobese type II diabetes mellitus in Asian patients. Surg Obes Relat Dis 2014;10(5):834-840. doi: 10.1016/j.soard.2014.01.018.
38. Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 2011;146(2):143-148.
39. Dixon JB, Chuang L, Chong K, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care 2013;36(1):20-26.
40. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993;328(23):1676-1685.
41. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348(5):383-393.
42. Romeo S, Maglio C, Burza MA, et al. Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care 2012;35(12):2613-2617.
43. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish Obese Subjects. N Engl J Med 2007;357(8):741-52.
44. Hou CC, Shyu RS, Lee WJ, et al. Improved renal function 12 months after bariatric surgery. Surg Obes Relat Dis 2013;9(2);202-206.
45. Neff KJ, Chuah LL, Aashiem ET, et al. Beyond Weight Loss: Evaluating the multiple benefits of bariatric surgery after Roux-en-Y gastric bypass and adjustable gastric band. Obese Surg 2014;24(5):684-691.
46. Hewitt S, Humerfelt S, Sovik TT, et al. Long-term improvements in pulmonary function 5 years after bariatric surgery. Obes Surg 2014;24(5):705-711.